GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 791 filers reported holding GLAXOSMITHKLINE PLC in Q2 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,559,000 | -2.6% | 35,810 | -2.5% | 0.14% | +10.2% |
| Q1 2022 | $1,600,000 | -61.4% | 36,733 | -60.9% | 0.13% | -59.8% |
| Q4 2021 | $4,144,000 | +5.6% | 93,956 | -8.5% | 0.32% | +0.3% |
| Q3 2021 | $3,923,000 | +321.8% | 102,661 | +339.5% | 0.32% | +325.7% |
| Q2 2021 | $930,000 | +167.2% | 23,360 | +139.6% | 0.07% | +155.2% |
| Q1 2021 | $348,000 | -42.8% | 9,750 | -41.0% | 0.03% | -47.3% |
| Q4 2020 | $608,000 | -40.6% | 16,533 | -39.2% | 0.06% | -46.1% |
| Q3 2020 | $1,023,000 | -34.2% | 27,180 | -28.7% | 0.10% | -36.6% |
| Q2 2020 | $1,554,000 | +7.0% | 38,107 | -0.6% | 0.16% | -7.5% |
| Q1 2020 | $1,452,000 | -24.1% | 38,326 | -5.9% | 0.17% | -3.3% |
| Q4 2019 | $1,913,000 | -28.9% | 40,713 | -35.4% | 0.18% | -31.8% |
| Q3 2019 | $2,690,000 | -19.7% | 63,019 | -24.7% | 0.26% | -20.2% |
| Q2 2019 | $3,348,000 | -9.5% | 83,657 | -5.5% | 0.33% | -12.0% |
| Q1 2019 | $3,698,000 | +0.3% | 88,494 | -8.3% | 0.38% | -10.3% |
| Q4 2018 | $3,687,000 | -5.5% | 96,475 | -0.7% | 0.42% | +7.2% |
| Q3 2018 | $3,901,000 | -0.8% | 97,117 | -0.5% | 0.39% | -15.4% |
| Q2 2018 | $3,933,000 | -4.7% | 97,574 | -7.6% | 0.46% | +3.6% |
| Q1 2018 | $4,128,000 | +83.3% | 105,626 | +66.4% | 0.45% | +80.6% |
| Q4 2017 | $2,252,000 | +37.5% | 63,483 | +57.3% | 0.25% | +32.1% |
| Q3 2017 | $1,638,000 | +165.0% | 40,350 | +181.6% | 0.19% | +159.7% |
| Q2 2017 | $618,000 | +15.7% | 14,331 | +13.2% | 0.07% | +12.5% |
| Q1 2017 | $534,000 | +64.3% | 12,659 | +50.0% | 0.06% | +48.8% |
| Q4 2016 | $325,000 | -34.1% | 8,442 | -26.1% | 0.04% | -29.5% |
| Q3 2016 | $493,000 | -37.5% | 11,420 | -37.3% | 0.06% | -40.2% |
| Q2 2016 | $789,000 | -25.6% | 18,204 | -30.4% | 0.10% | -29.2% |
| Q1 2016 | $1,060,000 | +10.9% | 26,150 | +10.5% | 0.14% | +9.9% |
| Q4 2015 | $956,000 | +11.2% | 23,671 | +5.9% | 0.13% | +9.2% |
| Q3 2015 | $860,000 | +23.4% | 22,361 | +33.7% | 0.12% | +29.0% |
| Q2 2015 | $697,000 | -2.9% | 16,728 | +7.5% | 0.09% | -2.1% |
| Q1 2015 | $718,000 | – | 15,558 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |